The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554

British Journal of Cancer

Volumn 77, Issue 1, 1998, Pages 65-70

  Aboagye, E O ^a,f   Maxwell, R J ^b   Horsman, M R ^c   Lewis, A D ^a,g   Workman, P ^a,h   Tracy, M ^d   Griffiths, J R ^e  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d SRI INTERNATIONAL   (United States)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HERIOT WATT UNIVERSITY   (United Kingdom)

^h ASTRAZENECA   (United Kingdom)

Author keywords

Fluorinated 2 nitroimidazole; Hypoxia probe; Magnetic resonance spectroscopy; pO2

Indexed keywords

2 (2 NITRO 1 IMIDAZOLYL) N (3,3,3 TRIFLUORO 2 HYDROXYPROPYL)ACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN ELECTRODE; PRIORITY JOURNAL; TISSUE OXYGENATION; TUMOR MODEL;

EID: 0031964711     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.10     Document Type: Article

References (32)

1. Aboagye EO, Lewis AD, Johnson A, Workman P, Tracy M and Huxham IM (1995a) The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semi-quantitative localization in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysis. Br J Cancer 72: 312-318
2. Aboagye EO, Graham MA, Lewis AD, Workman P, Kelson AB and Tracy M (1995b) Development and validation of a solid-phase extraction and high-performance liquid chromatographic assay for a novel flourinated 2-nitroimidazole hypoxia probe (SR-4554) in Balb/c mouse plasma. J Chromatogr B 672: 125-132
3. Aboagye EO, Lewis AD, Graham MA, Tracy M, Kelson AB, Ryan KJ & Workman P (1996) The pharmacokinetics, bioavailability, and biodistribution of a rationally designed 2-nitroimidazole hypoxia probe SR-4554. Anti-Cancer Drug Des 11: 231-242
4. Aboagye EO, Maxwell RJ, Kelson AB, Tracy M, Lewis AD, Graham MA, Horsman MR, Griffiths JR and Workman P (1997) Preclinical evaluation of the fluorinated 2-Nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia. Cancer Res 57: 3314-3318
5. Brizel DM, Rosner GL, Prosnitz LR and Dewhirst MW (1995) Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas and lymph node metastases. Int J Radiat Oncol Biol Phys 32: 1121-1125
6. Chaplin DJ and Horsman MR (1992) Tumour blood flow changes induced by chemical modifiers of radiation response. In J Radiat Oncol Biol Phys 22: 459-462
7. Chapman JD (1984) The detection and measurement of hypoxic cells in solid tumours. Cancer 54: 2441-2449
8. Chapman JD, Franko AJ and Sharplin J (1981) A marker for hypoxic cells in tumors with potential clinical applicability. Br J Cancer 43: 546-550
9. Chapman JD, Baer K and Lee J (1983) Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res 43: 1523-1528
10. Franko AJ, Koch CJ, Garrecht BM, Sharplin J & Hughes D (1987) Oxygen dependence of binding of misonidazole to rodent and human tumours in vitro. Cancer Res 47: 5367-5376
11. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH and Broder GJ (1988) Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14: 831-838
12. Horsman MR, Khalil AA, Siemann DW, Grau C, Hill SA, Lynch E, Chaplin DJ and Overgaard J (1994) Relationship between radiobiological hypoxia in tumours and electrode measurements of tumour oxygenation. Int J Radiat Oncol Biol Phys 29: 439-442
13. 19F magnetic resonance spectroscopy. Int J Radiat Biol 58: 1025-1034
14. Joseph P, Jaiswal AK, Stobbe CC and Chapman JD (1994) The role of specific reductases in the intracellular activation and binding of 2-nitroimidazoles. Int J Radiat Oncol Biol Phys 29: 351-355
15. 3H]misonidazole binding and paired survival assay. Radiat Res 145: 491-500
16. 13C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration. Int J Radiat Oncol Biol Phys 10: 1327-1332
17. Kolstad P (1968) Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand J Clin Lab Invest 22 (suppl. 106): 145-157
18. 19F magnetic resonance spectroscopy and immunohistochemistry. Radiat Res 129: 71-78
19. Lord EM, Harwell L and Koch CJ (1993) Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res 53: 5721-5726
20. 19F magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys 16: 925-929
21. Mueller-Klieser W, Schlenger KH, Walenta S, Gross M, Karbach U, Hoeckel M and Vaupel P (1991) Pathophysiological approaches to identifying tumor hypoxia in patients. Radiother Oncol 20 (suppl. 1): 21-28
22. Nordsmark M, Grau C, Horsman MR, Jorgensen HS and Overgaard J (1995). Relationship between tumour oxygenation, bioenergetic status and radiobiological hypoxia in an experimental model. Acta Oncol 34: 329-334
23. Okunieff P, Hoeckel M, Dunphy EP, Schlenger K, Knoop C and Vaupel P (1993) Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys 26: 631-636
24. Olive PL and Durand RE (1989) Misonidazole binding in SCCVII tumours in relation to the tumour blood supply. Int Radiat Oncol Biol Phys 16: 755-761
25. Overgaard J (1980) Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue. Br J Cancer 41: 10-21
26. 181F magnetic resonance method for measuring oxygen deficiency in tumours. Magn Reson Med 22: 451-466
27. 2 distribution and bioreductive enzymes in human malignant brain tumours. Int J Radiat Oncol Biol Phys 29: 427-431
28. 3′P MRS of tumour metabolism in anesthetized vs conscious mice. NMR Biomed 7: 167-171
29. Twentyman PR, Brown MJ, Gray JW, Franko AJ, Scoles MA and Kallman RF (1980) A new mouse tumour model system (RIF-1) for comparison of endpoint studies. J Natl Cancer Inst 64: 595-604
30. 2 tension measurements. Cancer Res 51: 3316-3322
31. Vaupel P, Schlenger KH, Hoeckel M and Okunieff P (1992) Oxygenation of mammary tumors: from isotransplanted rodent tumors to primary malignancies in patients. Adv Exp Med Biol 316: 361-371
32. 3′P NMR spectra in murine RIF-1 tumours. Magn Reson Med 33: 610-618